A Study Of BOTOX For The Treatment Of Glabellar Lines
Status:
Completed
Trial end date:
2007-05-09
Target enrollment:
Participant gender:
Summary
This is a Multicenter, double-blind, randomized, placebo-controlled, parallel-group
comparative study to confirm the efficacy and safety of BOTOX 20 units single injection for
the Chinese patients with glabellar lines. The subjects will receive a single intramuscular
treatment consisting of 5 injections of either BOTOX? 20U or placebo.
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA